Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Framiral is a French medical device company focused on the assessment, diagnosis, and rehabilitation of vestibular and balance disorders. The company designs, develops, manufactures, and sells specialized hardware and software used by healthcare professionals for vertigo, instability, and related neuro-otologic conditions. Its product portfolio includes videonystagmoscopy, dynamic visual acuity testing, rotary chair and stabilometry systems, optokinetic stimulation tools, and clinical software for vestibular testing and traceability. Founded in Cannes in 1991 and now based in Grasse, Framiral appears to operate as a specialized commercial-stage medtech business rather than a therapeutics developer. The company serves clinicians involved in vestibular rehabilitation and balance assessment in France and Europe, with some international distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Framiral.